Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akso Health (AHG) Payables (2017 - 2025)

Akso Health (AHG) has disclosed Payables for 7 consecutive years, with $1.1 million as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Payables rose 17.69% year-over-year to $1.1 million, compared with a TTM value of $1.1 million through Mar 2024, up 17.69%, and an annual FY2024 reading of $1.1 million, up 17.69% over the prior year.
  • Payables was $1.1 million for Q1 2024 at Akso Health, up from $938767.0 in the prior quarter.
  • Across five years, Payables topped out at $11.1 million in Q1 2021 and bottomed at $225881.0 in Q1 2022.
  • Average Payables over 5 years is $2.9 million, with a median of $1.1 million recorded in 2024.
  • The sharpest move saw Payables surged 869.25% in 2021, then crashed 97.97% in 2022.
  • Year by year, Payables stood at $1.1 million in 2020, then soared by 869.25% to $11.1 million in 2021, then plummeted by 97.97% to $225881.0 in 2022, then skyrocketed by 315.6% to $938767.0 in 2023, then grew by 17.69% to $1.1 million in 2024.
  • Business Quant data shows Payables for AHG at $1.1 million in Q1 2024, $938767.0 in Q1 2023, and $225881.0 in Q1 2022.